SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-009540
Filing Date
2024-02-01
Accepted
2024-02-01 18:01:55
Documents
1
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244961-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244961-3_4seq1.xml 4 9562
  Complete submission text file 0001104659-24-009540.txt   11245
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Harris Matthew Scott (Reporting) CIK: 0001787762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 24588157